Intelligence · Clinical Pipeline
Sarepta Therapeutics Pipeline
All ClinicalTrials.gov programs at Sarepta Therapeutics — phase, modality, and trial IDs.
- Programs
- 14
Quick answer
Sarepta Therapeutics has 14 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
AVI-4020 Injection
Sarepta Therapeutics
West Nile Fever
1 trial -
AVI-4020 Injection
Sarepta Therapeutics
West Nile Virus
1 trial -
AVI-4065 Injection
Sarepta Therapeutics
Encephalitis
1 trial -
AVI-4126 Injection (RESTEN-NG®)
Sarepta Therapeutics
Neoplasms
1 trial -
AVI-6003
Sarepta Therapeutics
Marburg Hemorrhagic Fever
1 trial -
AVI-7100
Sarepta Therapeutics
Influenza
1 trial -
AVI-7288
Sarepta Therapeutics
Marburg Hemorrhagic Fever
1 trial -
AVI-7537
Sarepta Therapeutics
Ebola Hemorrhagic Fever
1 trial -
Idefirix 11 mg powder for concentrate for solution for infusion, Delandistrogene moxeparvovec-rokl
Sarepta Therapeutics
Duchenne muscular dystrophy (DMD)
1 trial -
Placebo
Sarepta Therapeutics
Ebola Hemorrhagic Fever
1 trial -
SRP-1005
Sarepta Therapeutics
Huntington's Disease
1 trial -
SRP-6004
Sarepta Therapeutics
Limb Girdle Muscular Dystrophy
1 trial -
SRP-9004
Sarepta Therapeutics
Limb Girdle Muscular Dystrophy
1 trial -
rAAVrh74.MHCK7.DYSF.DV
Sarepta Therapeutics
Dysferlinopathy
1 trial
Frequently asked questions
How many pipeline programs does Sarepta Therapeutics have?
14 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs